Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00507455 · ClinicalTrials.gov registry record · Phase 2
Solifenacin Succinate With Tamsulosin HCl in Males With Lower Urinary Tract Symptoms and Bladder Outlet Obstruction
A Phase 2 study of Lower Urinary Tract Symptoms and Bladder Outlet Obstruction, sponsored by Astellas Pharma.
- Completed
- Registry status
- Phase 2
- Development phase
- 222
- Enrollment target
- 20
- Study locations
NCT00507455 is a Phase 2 study of Lower Urinary Tract Symptoms and Bladder Outlet Obstruction that has completed, run by Astellas Pharma. The registered enrollment target is 222 participants, below the 740-participant average among 21 other Lower Urinary Tract Symptoms trials with a reported enrollment target (70% lower). The trial reports 20 study locations across 13 states.
The verdict
NCT00507455, a Phase 2 study of Lower Urinary Tract Symptoms and Bladder Outlet Obstruction, has completed, sponsored by Astellas Pharma.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 222 participants
- Enrollment target
- 20
- Study locations
Study Summary
A study to evaluate the safety of the co-administration of solifenacin succinate with tamsulosin hydrochloride in men with lower urinary tract symptoms (LUTS) and bladder outlet obstruction (BOO).
Conditions Studied
Interventions
- DRUG solifenacin succinate
- DRUG tamsulosin hydrochloride
- DRUG Placebo to solifenacin
- DRUG Placebo to tamsulosin
Study Locations (20)
California
- - La Mesa
- - Long Beach
- - San Bernardino
- - San Diego
Other
- - Edegem
- - Kortrijk
- - Olomouc
Iowa
- - Des Moines
- - Iowa City
Texas
- - Austin
- - San Antonio
Alabama
- - Homewood
Connecticut
- - Middlebury
Florida
- - New Port Richey
Idaho
- - Coeur d'Alene
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 222 participants |
| Start Date | 2007-06 |
| Est. Completion | 2008-08 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00507455
The ClinicalTrials.gov registry entry for NCT00507455 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 222 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 740-participant average among 21 other Lower Urinary Tract Symptoms trials with a reported enrollment target (70% lower). The listed sponsor is Astellas Pharma, which has 165 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Lower Urinary Tract Symptoms appearing as the primary indexed condition, and to 4 interventions - of which solifenacin succinate is the first listed.
NCT00507455 reports 20 study locations spanning 13 distinct geographic areas - top geographies include California, Other, Iowa.
Frequently Asked Questions
What is clinical trial NCT00507455 about?
NCT00507455 is a clinical study titled "Solifenacin Succinate With Tamsulosin HCl in Males With Lower Urinary Tract Symptoms and Bladder Outlet Obstruction". A study to evaluate the safety of the co-administration of solifenacin succinate with tamsulosin hydrochloride in men with lower urinary tract symptoms (LUTS) and bladder outlet obstruction (BOO).
What is the current status of trial NCT00507455?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 222 participants. The study started on 2007-06. Estimated completion is 2008-08.
What conditions does trial NCT00507455 study?
This clinical trial studies the following conditions: Lower Urinary Tract Symptoms, Bladder Outlet Obstruction.
What interventions are being tested in trial NCT00507455?
The interventions under investigation include: solifenacin succinate (DRUG), tamsulosin hydrochloride (DRUG), Placebo to solifenacin (DRUG), Placebo to tamsulosin (DRUG).
Who is sponsoring clinical trial NCT00507455?
This trial is sponsored by Astellas Pharma, which has 165 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00507455 being conducted?
This trial has 20 study locations across Alabama, California, Connecticut, Florida, Idaho. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lower Urinary Tract Symptoms
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Testing MitoQ on Lower Urinary Tract Symptoms in Older Women With Metabolic Syndrome
RECRUITING · Phase 2
-
Impact of Probiotics on Urinary Symptoms in Spinal Cord Injury SCI and SB
COMPLETED · Phase 2
-
Combined Behavioral and Drug Treatment of Overactive Bladder in Men
COMPLETED · Phase 2
-
An 8-week, Open-label, Uncontrolled Study of Tamsulosin 0.4mg in Men With Bothersome Urinary Symptoms
COMPLETED · Phase 2
-
US Imaging for the Assessment of LUTS
RECRUITING
-
Preoperative Pelvic Floor Physical Therapy to Minimize Stress Urinary Incontinence After Holmium Laser Enucleation of the Prostate
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.